logo

Stock Screener

Forex Screener

Crypto Screener

SXT

Sensient Technologies Corporation (SXT)

$

114.8

+1.26 (1.10%)


Key metrics

Financial statements

Free cash flow per share

Free cash flow per share

1.4948

Market cap

Market cap

4.9 Billion

Price to sales ratio

Price to sales ratio

3.0942

Debt to equity

Debt to equity

0.6364

Current ratio

Current ratio

4.2452

Income quality

Income quality

1.0198

Average inventory

Average inventory

608.9 Million

ROE

ROE

0.1228



Technology

Technology

Technology – consumer electronics

Largecap

Largecap

With a market cap of 121,78 bil stock is ranked 1

Low risk

Low risk

ISS score of this stock is ranked 1


Company description

Profile

Sensient Technologies Corporation, along with its subsidiaries, excels in the development, manufacturing, and marketing of colors, flavors, and specialty ingredients across North America, Europe, the Asia Pacific, and globally. The company operates through three primary segments: Flavors & Extracts Group, Color Group, and Asia Pacific Group. Sensient offers an array of flavor-delivery systems and compounded products, alongside essential ingredients like essential oils, natural and synthetic flavors, and natural extracts. Additionally, their product offerings include chili powder, paprika, and chili pepper, as well as a variety of dehydrated vegetables such as parsley, celery, and spinach tailored for the food, beverage, personal care, and household-products sectors. The net income ratio is 0.08 reflecting the company's profitability margin. Moreover, the cost of revenue for the company is $1,050,135,000.00 showcasing its production and operational expenses. The EBITDA ratio is 0.16 highlighting the company's operational efficiency, while the gross profit stands at $507,093,000.00 demonstrating the company's profitability from core operations. Lastly, the income before tax ratio is 0.10 reflecting the pre-tax margin, which signifies the effectiveness of Sensient's financial management practices. The stock is reasonably priced at $109.46 appealing to a broad range of investors who are seeking stable opportunities. However, the stock has a low average trading volume of 453,430.00 indicating lower market activity, which may suggest a more cautious investment approach. With a mid-range market capitalization of $4,875,108,280.00 the company is a steady performer in the competitive landscape of the market. It is a key player in the Chemicals - Specialty industry, contributing significantly to the overall market landscape. Additionally, it belongs to the Basic Materials sector, driving innovation and growth, thus making it an attractive option for investors looking for sustained development in their portfolios.

What is Sensient Technologies Corporation (SXT)'s current stock price?

The current stock price of Sensient Technologies Corporation (SXT) is $114.33 as of 2025-08-29. Prices may fluctuate during the trading day. For real-time updates, check your brokerage platform or financial news websites.

Investing in Sensient Technologies Corporation (SXT) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B, with a Bearish outlook. Always conduct your own research before investing.

Analysts predict Sensient Technologies Corporation stock to fluctuate between $66.15 (low) and $121.54 (high) in the next 365 days, reflecting market expectations and potential volatility.

As of 2025-08-29, Sensient Technologies Corporation's market cap is $4,875,108,280, based on 42,466,100 outstanding shares.

Compared to The Sherwin-Williams Company, Sensient Technologies Corporation has a Lower Market-Cap, indicating a difference in performance.

Sensient Technologies Corporation pays dividends. The current dividend yield is 1.45%, with a payout of $0.41 per share.

To buy Sensient Technologies Corporation (SXT) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for SXT. Place an order (Market, Limit, etc.).

The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.

Sensient Technologies Corporation's last stock split was 2:1 on 1998-05-26.

Revenue: $1,557,228,000 | EPS: $2.96 | Growth: 33.33%.

Visit https://www.sensient.com/investor-relations for detailed financial reports.

You can explore historical data from here

All-time high: $121.54 (2025-08-14) | All-time low: $52.90 (2023-10-13).

Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.


News

SXT

seekingalpha.com

Sensient Technologies: Ingredients Play Is Riding The Tougher Food Regulation Trend

Sensient Technologies has seen a sharp share price rally, driven by hopes for regulatory tailwinds and healthier food trends, despite modest operational improvements. Recent earnings and sales growth are solid but not spectacular, with valuation multiples now stretched to 33-34x earnings after the stock's 50% surge. The business could benefit from stricter regulations on artificial ingredients, but the impact and timing remain uncertain, making me cautious at current levels.

SXT

fool.com

Sensient Posts 22% Profit Gain in Q2

Sensient Posts 22% Profit Gain in Q2

SXT

seekingalpha.com

Sensient Technologies Corporation (SXT) Q2 2025 Earnings Call Transcript

Sensient Technologies Corporation (NYSE:SXT ) Q2 2025 Earnings Conference Call July 25, 2025 9:30 AM ET Company Participants Paul Manning - Chairman, CEO, President & Member of Scientific Advisory Committee Tobin Tornehl - VP & CFO Conference Call Participants David Paul Green - Boldhaven Management LLP Ghansham Panjabi - Robert W. Baird & Co. Incorporated, Research Division Lawrence Scott Solow - CJS Securities, Inc. Nicola Tang - BNP Paribas Exane, Research Division Operator Good morning, and welcome to the Sensient Technologies Corporation 2025 Second Quarter Earnings Conference Call.

SXT

businesswire.com

Sensient Technologies Corporation Reports Results for the Quarter Ended June 30, 2025

MILWAUKEE--(BUSINESS WIRE)--Sensient Technologies Corporation (NYSE: SXT), a leading provider of flavors and colors for the food, pharmaceutical, and personal care markets, today reported financial results for the second quarter ended June 30, 2025. Second Quarter Consolidated Results Reported revenue increased 2.7% to $414.2 million in the second quarter of 2025 versus last year's second quarter results of $403.5 million. On a local currency basis(1), revenue increased 2.1%. Reported operating.

SXT

businesswire.com

Sensient Declares Dividend

MILWAUKEE--(BUSINESS WIRE)--The Board of Directors of Sensient Technologies Corporation (NYSE: SXT) has declared a regular quarterly cash dividend on its common stock of $0.41 per share. The cash dividend will be paid on September 2, 2025, to shareholders of record on August 4, 2025. About Sensient Technologies Sensient Technologies Corporation is a leading global manufacturer and marketer of colors, flavors, and other specialty ingredients. Sensient uses advanced technologies and robust global.

SXT

businesswire.com

Sensient Announces Conference Call

MILWAUKEE--(BUSINESS WIRE)--Sensient Technologies Corporation (NYSE: SXT) will hold its earnings call and webcast to discuss 2025 second quarter results at 8:30 a.m. CDT on Friday, July 25, 2025. Investors may access the live webcast on the Company's web site at investor.sensient.com. Alternatively, investors may join the conference call by contacting Chorus Call Inc. at (844) 492-3726 or (412) 317-1078. A webcast replay will be available on the Company's web site following the call. The call t.

SXT

seekingalpha.com

Sensient Technologies Corporation (SXT) Q1 2025 Earnings Call Transcript

Sensient Technologies Corporation (NYSE:SXT ) Q1 2025 Earnings Conference Call April 25, 2025 9:30 AM ET Company Participants Tobin Tornehl - Vice President and Chief Financial Officer Paul Manning - Chairman, President and Chief Executive Officer Conference Call Participants Ghansham Panjabi - Baird Nicola Tang - BNP Paribas David Green - Boldhaven Operator Good morning, everyone, and welcome to the Sensient Technologies Corporation 2025 First Quarter Earnings Conference Call. All participants will be in listen-only mode.

SXT

businesswire.com

Sensient Announces Conference Call

MILWAUKEE--(BUSINESS WIRE)--Sensient Technologies Corporation (NYSE: SXT) will hold its earnings call and webcast to discuss 2025 first quarter results at 8:30 a.m. CDT on Friday, April 25, 2025. Investors may access the live webcast on the Company's web site at investor.sensient.com. Alternatively, investors may join the conference call by contacting Chorus Call Inc. at (844) 492-3726 or (412) 317-1078. A webcast replay will be available on the Company's web site following the call. The call t.

SXT

globenewswire.com

China SXT Pharmaceuticals Has Regained Compliance with Nasdaq's Minimum Bid Price Deficiency

TAIZHOU, China, March 17, 2025 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (Nasdaq: SXTC) (the “Company”),  a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”), today announced that the Company received a written notification (the “Compliance Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) dated March 13, 2025, informing the Company that it has regained compliance with the Nasdaq Listing Rule 5550(a)(2) (“Minimum Bid Price Requirement”) and the matter is closed.

SXT

globenewswire.com

China SXT Pharmaceuticals, Inc. Announces Share Consolidation

TAIZHOU, China, Feb. 21, 2025 (GLOBE NEWSWIRE) -- China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the “Company” or “SXTC”),  a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”), today announced that it will effect a share consolidation of its ordinary shares at a ratio of 1-for-8, effective on February 25, 2025 (the “Share Consolidation”). The Company's ordinary shares are expected to begin trading on a post-consolidation basis at the open of the market session on February 25, 2025. Upon the market opening on February 25, 2025, the Company's ordinary shares will continue to be traded on The Nasdaq Stock Market under the symbol “SXTC” with the new CUSIP number G2161P157.

See all news

logo
Stocks, Indicators, Pattern screeners all at one place
Stock Screener
Forex Screener
Crypto Screener